Literature DB >> 11849862

C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

James S Zebrack1, Joseph B Muhlestein, Benjamin D Horne, Jeffrey L Anderson.   

Abstract

OBJECTIVES: The objective of this study was to determine the prognostic value of C-reactive protein (CRP) independent of coronary angiographic findings.
BACKGROUND: High sensitivity CRP, a marker of inflammation, predicts risk of cardiovascular events. However, it is uncertain whether it remains predictive once angiographic findings are considered.
METHODS: A total of 2,554 patients with angina but without acute myocardial infarction (MI) were studied angiographically; 1,848 patients had coronary artery disease (CAD) and 706 patients did not. Coronary artery disease was quantified in five ways and combined for a CAD score. C-reactive protein was measured and patients were followed for up to five years for death or MI.
RESULTS: C-reactive protein correlated with the extent of CAD, but correlation coefficients were low (0.02 to 0.08). Of angiographic measures, the CAD score best predicted future events (hazard ratio [HR] = 1.8 [1.2 to 2.6], p = 0.004, for CAD score > 4). C-reactive protein > or = 1.0 mg/dl was predictive in both patients without CAD (HR = 2.3 [0.9 to 5.5], p = 0.07) and with CAD (HR = 2.1 [1.5 to 3.1], p = 0.0001). Multivariate adjustment resulted in little change in HR. C-reactive protein retained predictive value within each quintile of CAD score. C-reactive protein and CAD independently and additively contributed to the risk prediction: low CRP and lowest CAD score was associated with lowest risk, and high CRP and highest CAD score was associated with the highest risk, with a 10-fold difference between extremes (2.5% vs. 24%).
CONCLUSIONS: C-reactive protein correlates with extent of CAD, but the degree of correlation is low. Severity/extent of CAD and CRP are independent and additive predictors of risk. Therapy should target CRP-associated risk as well as angiographically evident stenosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849862     DOI: 10.1016/s0735-1097(01)01804-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  41 in total

1.  Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients.

Authors:  Steven Rosenberg; Michael R Elashoff; Philip Beineke; Susan E Daniels; James A Wingrove; Whittemore G Tingley; Philip T Sager; Amy J Sehnert; May Yau; William E Kraus; L Kristin Newby; Robert S Schwartz; Szilard Voros; Stephen G Ellis; Naeem Tahirkheli; Ron Waksman; John McPherson; Alexandra Lansky; Mary E Winn; Nicholas J Schork; Eric J Topol
Journal:  Ann Intern Med       Date:  2010-10-05       Impact factor: 25.391

2.  Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease.

Authors:  Gjin Ndrepepa; Tomohisa Tada; Massimiliano Fusaro; Salvatore Cassese; Lamin King; Martin Hadamitzky; Hans-Ullrich Haase; Albert Schömig; Adnan Kastrati; Jürgen Pache
Journal:  Clin Res Cardiol       Date:  2012-07-08       Impact factor: 5.460

3.  Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome.

Authors:  Wen Ni Tiong; Edmund Ui Hang Sim; Alan Yean Yip Fong; Tiong Kiam Ong
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

Review 4.  Chronic inflammatory muscle diseases and risk of coronary artery disease.

Authors:  Betul M Gundogdu; Mehmet Cilingiroglu
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

5.  C-reactive protein in unstable angina: clinical and angiographic correlation.

Authors:  Prashanth Panduranga; Abdulla A Riyami; Kadhim J Sulaiman; Mohammed Mukhaini
Journal:  Heart Asia       Date:  2010-01-01

6.  The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening.

Authors:  Gregory A Payne; Edgar Turner Overton
Journal:  J Nucl Cardiol       Date:  2016-11-16       Impact factor: 5.952

7.  C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.

Authors:  Mary S Beattie; Michael G Shlipak; Haiying Liu; Warren S Browner; Nelson B Schiller; Mary A Whooley
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.

Authors:  Olivier Gach; Olivier Louis; Jean Paul Chapelle; Sophie Vanbelle; Luc A Pierard; Victor Legrand
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

9.  Association of inflammatory markers with the morphology and extent of coronary plaque as evaluated by 64-slice multidetector computed tomography in patients with stable coronary artery disease.

Authors:  Ken Harada; Tetsuya Amano; Tadayuki Uetani; Tomohiro Yoshida; Bunichi Kato; Masataka Kato; Nobuyuki Marui; Soichiro Kumagai; Hirohiko Ando; Hideki Ishii; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Int J Cardiovasc Imaging       Date:  2013-01-29       Impact factor: 2.357

10.  Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.

Authors:  Peter R Sinnaeve; Mark P Donahue; Peter Grass; David Seo; Jacky Vonderscher; Salah-Dine Chibout; William E Kraus; Michael Sketch; Charlotte Nelson; Geoffrey S Ginsburg; Pascal J Goldschmidt-Clermont; Christopher B Granger
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.